EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,712 | -46.7% | 2,645 | -34.4% | 0.00% | – |
| Q2 2023 | $78,323 | +1.1% | 4,029 | +47.6% | 0.00% | – |
| Q1 2023 | $77,450 | +447.5% | 2,730 | +464.0% | 0.00% | – |
| Q4 2022 | $14,147 | -54.4% | 484 | -57.6% | 0.00% | – |
| Q3 2022 | $31,000 | -35.4% | 1,142 | +3.9% | 0.00% | – |
| Q2 2022 | $48,000 | -97.7% | 1,099 | -97.4% | 0.00% | -100.0% |
| Q1 2022 | $2,081,000 | -7.2% | 42,059 | -4.5% | 0.00% | 0.0% |
| Q4 2021 | $2,243,000 | -84.8% | 44,055 | -83.3% | 0.00% | -66.7% |
| Q3 2021 | $14,716,000 | +97.9% | 263,821 | +51.8% | 0.00% | +50.0% |
| Q2 2021 | $7,437,000 | +234.4% | 173,765 | +226.1% | 0.00% | +100.0% |
| Q1 2021 | $2,224,000 | +5.5% | 53,292 | +17.7% | 0.00% | 0.0% |
| Q4 2020 | $2,109,000 | +45.9% | 45,295 | +33.1% | 0.00% | – |
| Q3 2020 | $1,446,000 | -10.6% | 34,029 | +0.9% | 0.00% | – |
| Q2 2020 | $1,617,000 | +9.4% | 33,711 | +4.9% | 0.00% | -100.0% |
| Q1 2020 | $1,478,000 | -29.2% | 32,124 | -7.5% | 0.00% | 0.0% |
| Q4 2019 | $2,087,000 | +8.4% | 34,735 | +2.0% | 0.00% | 0.0% |
| Q3 2019 | $1,926,000 | +21.8% | 34,056 | +19.9% | 0.00% | – |
| Q2 2019 | $1,581,000 | +25.7% | 28,410 | +14.0% | 0.00% | – |
| Q1 2019 | $1,258,000 | +36.7% | 24,930 | +9.0% | 0.00% | – |
| Q4 2018 | $920,000 | -31.4% | 22,865 | +18.2% | 0.00% | – |
| Q3 2018 | $1,342,000 | -22.5% | 19,339 | -15.5% | 0.00% | -100.0% |
| Q2 2018 | $1,732,000 | +41.0% | 22,889 | -1.7% | 0.00% | – |
| Q1 2018 | $1,228,000 | +12.9% | 23,287 | +14.4% | 0.00% | – |
| Q4 2017 | $1,088,000 | -15.2% | 20,351 | -5.4% | 0.00% | – |
| Q3 2017 | $1,283,000 | +2.6% | 21,506 | +35.5% | 0.00% | – |
| Q2 2017 | $1,251,000 | +14.2% | 15,866 | +20.2% | 0.00% | – |
| Q1 2017 | $1,095,000 | -21.3% | 13,203 | -24.7% | 0.00% | – |
| Q4 2016 | $1,391,000 | +211.9% | 17,541 | +175.2% | 0.00% | – |
| Q3 2016 | $446,000 | +211.9% | 6,375 | +73.8% | 0.00% | – |
| Q2 2016 | $143,000 | -1.4% | 3,668 | +2.6% | 0.00% | – |
| Q1 2016 | $145,000 | -83.6% | 3,574 | -64.2% | 0.00% | – |
| Q4 2015 | $885,000 | -35.8% | 9,988 | -46.4% | 0.00% | -100.0% |
| Q3 2015 | $1,379,000 | +502.2% | 18,629 | +557.1% | 0.00% | – |
| Q2 2015 | $229,000 | -28.9% | 2,835 | -63.2% | 0.00% | – |
| Q1 2015 | $322,000 | +147.7% | 7,704 | -8.4% | 0.00% | – |
| Q4 2014 | $130,000 | +1757.1% | 8,409 | +1581.8% | 0.00% | – |
| Q2 2014 | $7,000 | -30.0% | 500 | -37.5% | 0.00% | – |
| Q1 2014 | $10,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |